“Blockbuster Growth Potential”: read the article on Cynata in Motley Fool

Cynata is an exciting stem cell and regenerative medicine company with the ability to produce an unlimited number of stem cells at a low cost through its Cymerus technology. Japan-based Fujifilm recently bought a 10% stake in the company as part of its push to become a world leader in stem cell supply and technology…

Read the full article on Motley Fool